Contrast-enhanced bowel ultrasound in the diagnosis of inflammatory bowel disease: a literature review
https://doi.org/10.31146/1682-8658-ecg-237-5-118-126
Abstract
Intestinal ultrasound using microbubble contrast agents or contrast-enhanced ultrasound (CEUS), is promising investigation allowing to perform quantitative and qualitative assessment of inflammatory changes of the intestinal wall such as its thickening, changes of the structure and abnormal microcirculation. This changes correlate with inflammation intensity and help to reveal complications including abscesses, strictures and fistulas in patients with Crohn’s disease. There has been established high sensitivity and moderate specificity of the method in diagnosis of active Inflammatory bowel disease (IBD). Because IBD is a chronic condition requiring frequent visualization to control treatment efficacy which should be safe, not expensive and accurate. CEUS fits these requirements and is not inferior to Computed Tomography and Magnetic Resonance Imaging.
About the Authors
D. D. Mukhametova
Kazan State Medical University
Russian Federation
Russian Federation
L. R. Ismailova
Kazan State Medical University
Russian Federation
Russian Federation
D. I. Abdulganieva
Kazan State Medical University
Russian Federation
Russian Federation
References
1. Maev I.V., Bakulin I.G., Skalinskaya M.I., Skazyvaeva E.V. Inflammatory bowel diseases: Transformation of representations. A review. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(12):1064-1074. (In Russ.) doi: 10.26442/00403660.2023.12.202507.@@ Маев И.В., Бакулин И.Г., Скалинская М.И., Сказываева Е.В. Воспалительные заболевания кишечника: трансформация представлений. Терапевтический архив. 2023;95(12):1064-1074. doi: 10.26442/00403660.2023.12.202507.
2. Lomakina E. Yu., Budzinskaya A.A., Belousova E.A., Tereschenko S.G. The role of clarifying endoscopic techniques in determining the degree of activity in patients with inflammatory bowel diseases. Experimental and Clinical Gastroenterology. 2024;225(5):43-50. (In Russ.) doi: 10.31146/1682-8658-ecg-225-5-43-50.@@ Ломакина Е.Ю., Будзинская А.А., Белоусова Е.А., Терещенко С.Г. Роль уточняющих эндоскопических методик в определении степени активности у пациентов с воспалительными заболеваниями кишечника. Экспериментальная и клиническая гастроэнтерология. 2024;225(5):43-50. doi: 10.31146/1682-8658-ecg-225-5-43-50.
3. Tagliamonte G., Santagata F., Fraquelli M. Current Developments and Role of Intestinal Ultrasound including the Advent of AI. Diagnostics (Basel). 2024;14(7):759. doi: 10.3390/diagnostics14070759.
4. Shelygin Y.A. et al. Clinical guidelines. Crohn’s disease (К50), adults. Koloproktologia. 2023;22(3):10-49. (in Russ.) doi: 10.33878/2073-7556-2023-22-3-10-49.@@ Шелыгин Ю.А. и соавт. Клинические рекомендации. Болезнь Крона (К50), взрослые. Колопроктология. 2023;22(3):10-49. doi: 10.33878/2073-7556-2023-22-3-10-49.
5. Shelygin Y.A., Ivashkin V.T., Belousova E.A. et al. Clinical guidelines Ulcerative colitis (K51), adults. Koloproktologia. 2023;22(1):10-44. (in Russ.) doi: 10.33878/2073-7556-2023-22-1-10-44.@@ Шелыгин Ю.А., Ивашкин В.Т., Белоусова Е.А. и соавт. Язвенный колит (К51), взрослые. Колопроктология. 2023;22(1):10-44. doi: 10.33878/2073-7556-2023-22-1-10-44.
6. Sturm A., Maaser C., Calabrese E. at al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects. Journal of Crohn’s & colitis. 2019;13(3):273-284. doi:10.1093/ecco-jcc/jjy114.
7. Horsthuis K., Bipat S., Bennink R.J. et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247(1):64-79. doi: 10.1148/radiol.2471070611.
8. Panes J., Bouhnik Y., Reinisch W. et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis. 2013;7:556-85. doi: 10.1016/j.crohns.2013.02.020.
9. Sasaki T., Kunisaki R., Kinoshita H. et al. Use of color Doppler ultrasonography for evaluating vascularity of small intestinal lesions in Crohn’s disease: correlation with endoscopic and surgical macroscopic findings. Scand J Gastroenterol. 2014;49:295-301. doi: 10.3109/00365521.2013.871744.
10. Maconi G., Nylund K., Ripolles T. et al. EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in Inflammatory Bowel Diseases. Ultraschall Med. 2018;39(3):304-317. doi:10.1055/s-0043-125329.
11. Strobel D., Goertz R.S., Bernatik T. Diagnostics in inflammatory bowel disease: Ultrasound. World J Gastroenterol. 2011;17(27):3192-3197. doi: 10.3748/wjg.v17.i27.3192.
12. Atkinson N.S.S., Bryant R.V., Dong Y. et al. How to perform gastrointestinal ultrasound: Anatomy and normal findings. World J Gastroenterol. 2017; 23(38): 6931-6941. doi: 10.3748/wjg.v23.i38.6931.
13. Felicani C., Trovati A., Franchi E. et al. Transabdominal Gastro-Intestinal UltraSound (GIUS): a visual approach to intestinal pathology. Explor Dig Dis. 2024;3:241-61. doi: 10.37349/edd. 2024.00050.
14. Richard N., Savoye G., Leboutte M., Amamou A., Ghosh S., Marion-Letellier R. Crohn’s disease: Why the ileum?. World J Gastroenterol. 2023;29(21):3222-3240. doi: 10.3748/wjg.v29.i21.3222.
15. Jauregui-Amezaga A., Rimola J. Role of Intestinal Ultrasound in the Management of Patients with Inflammatory Bowel Disease. Life. 2021;11:603. doi: 10.3390/ life11070603.
16. Martínez Pérez M.J., Blanc García E., Merino Bonilla J.A. Bowel ultrasound: examination techniques and normal and pathologic patterns. Radiologia (Engl Ed). 2020;62(6):517-527. doi: 10.1016/j.rx.2020.09.004.
17. Kucharzik T., Kannengiesser K., Petersen F. The use of ultrasound in inflammatory bowel disease. Ann Gastroenterol. 2017;30(2):135-144. doi: 10.20524/aog.2016.0105.
18. Calabrese E., Petruzziello C., Onali S. et al. Severity of postoperative recurrence in Crohn’s disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis. 2009;15:1635-1642. doi: 10.1002/ibd.20948.
19. Furfaro F., Dal Buono A., Allocca M. et al. Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale? Life. 2021;11:649. doi: 10.3390/life11070649.
20. Dubrova S.E., Stashuk G.A. The potential of radiologic procedures in the diagnosis of inflammatory bowel disease. Almanac of Clinical Medicine. 2016;44.6:757-769 (In Russ.) doi: 10.18786/2072-0505-2016-44-6-757-769.@@ Дуброва С.Э., Сташук Г.А. Возможности лучевых методов в диагностике воспалительных заболеваний кишечник. Альманах клинической медицины. 2016;44.6:757-769. doi: 10.18786/2072-0505-2016-44-6-757-769.
21. Calavrezos L., Bannas P., Warncke M., Wiegard C., Huber S., Manthey C. Transabdominal Ultrasound and Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Observational Retrospective Single-Center Study. Ultrasound Int Open. 2022;8(1): E22-E28. doi: 10.1055/a-1781-4410.
22. Kim N., Hausken T., Gilja O. Ultrasound and inflammatory bowel disease. Ultrasound quarterly. 2010: 3-15. doi: 10.1097/RUQ.0b013e3181ce0929.
23. Jauregui-Amezaga A., Rimola J. Role of Intestinal Ultrasound in the Management of Patients with Inflammatory Bowel Disease. Life (Basel). 2021;11(7):603. doi: 10.3390/life11070603.
24. Romanini L., Passamonti M., Navarria M. et al. Quantitative analysis of contrast-enhanced ultra-sonography of the bowel wall can predict disease activity in inflammatory bowel disease. EurJRadiol. 2014;83:1317-23. doi: 10.1016/j.ejrad.2014.05.012.
25. Novikov N.E. Contrast-enhanced ultrasound. History and modern features. REJR. 2012;2(1): 20-28. (In Russ.)@@ Новиков Н.Е. Контрастно-усиленные ультразвуковые исследования. История развития и современные возможности. REJR. 2012;2(1):20-28.
26. Mironova O. Iu., Isaikina M.A., Isaev G.O., Berdysheva M.V., Fomin V.V. Contrast-enhanced ultrasound: history, application and perspectives. Terapevticheskii Arkhiv (Ter.Arkh.). 2023;95(4):354-358. (in Russ.) doi:10.26442/00403660.2023.04.202157.@@ Миронова О.Ю., Исайкина М.А., Исаев Г.О., Бердышева М.В., Фомин В.В. Ультразвуковые исследования с контрастированием: история, применение в практике и перспективы. Терапевтический архив. 2023;95(4):354-358. doi: 10.26442/00403660.2023.04.202157.
27. Ignee A., Atkinson N.S.S., Schuessler G., Dietrich C.F. Ultrasound contrast agents. Endosc Ultrasound. 2016;5(6):355-362. doi: 10.4103/2303-9027.193594.
28. Jakobsen J.A. Ultrasound contrast agents: clinical applications. Eur Radiol. 2001;11:1329-1337 doi: 10.1007/s003300100964.
29. Fomina S.V., Zavadovskaya V.D., Yusubov M.S., Drygunova L.A., Filimonov V.D. Contrast agents for ultrasound examination. Bulletin of Siberian Medicine. 2011;10(6):137-141. (In Russ.) doi: 10.20538/1682-0363-2011-6-137-141.@@ Фомина С.В., Завадовская В.Д., Юсубов М.С., Дрыгунова, Л.А., Филимонов В.Д. Контрастные препараты для ультразвукового исследования. Бюллетень сибирской медицины. 2011;10(6):137-141. doi: 10.20538/1682-0363-2011-6-137-141.
30. Medellin A., Merrill C., Wilson S.R. Role of contrast-enhanced ultrasound in evaluation of the bowel. Abdom Radiol (NY). 2018;43(4):918-933. doi: 10.1007/s00261-017-1399-6.
31. Ripollés T., Martínez-Pérez M.J., Blanc E. et al. Contrast-enhanced ultrasound (CEUS) in Crohn’s disease: technique, image interpretation and clinical applications. Insights Imaging. 2011;2(6):639-652. doi: 10.1007/s13244-011-0124-1.
32. Sidhu P.S., Cantisani V., Dietrich C.F. et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med. 2018;39(2): e2-e44. doi: 10.1055/a-0586-1107.
33. Zubarev A.V., Fedorova A.A., Chernishev V.V., Varlamov G.V., Sokolova N.A., Fedorova N.A. Application of Contrast Enhanced Ultrasound (Ceus) in the Clinic and Prospects of Synchronization Ultrasound, CT and MRI Images (Personal Experience and Literature Review). Medical Visualization. 2015;(1):94-114. (In Russ.)@@ Зубарев А.В., Фёдорова А.А., Чернышев В.В., Варламов Г.В., Соколова Н.А., Федорова Н.А. Применение эхоконтрастных препаратов в клинике и перспективы синхронизации УЗИ, КТ- и МРТ-изображений (собственный опыт и обзор литературы). Медицинская визуализация. 2015;(1):94-114.
34. Description of the drug in the Vidal reference book [Electronic resource]. Vidal.ru: reference book of medicines. (in Russ.) Available at: https://www.vidal.ru/drugs/sonovue__40866 (Accessed: 01/14/2025). @@ Описание препарата в справочнике Видаль [Электронный ресурс]. Vidal.ru: справочник лекарственных средств. URL https://www.vidal.ru/drugs/sonovue__40866 (дата обращения: 14.01.2025).
35. Schneider M. Characteristics of SonoVue trade mark. Echocardiography. 1999;16(7/2):743-746. doi: 10.1111/j.1540-8175.1999.tb00144.x.
36. Fomin V.V., Ternovoy S.K., Makhov V.M. et al. Ultrasound examination with contrast in the diagnosis of inflammatory bowel disease. The results of the pilot study. Terapevticheskii arkhiv. 2018;90(2):53-58. (in Russ.) doi: 10.26442/terarkh201890253-58.@@ Фомин В.В., Терновой С.К., Махов В.М. [и др.] Ультразвуковое исследование с контрастированием в диагностике воспалительных заболеваний кишечника. Результаты пилотного исследования. Терапевтический архив. 2018;2:53-58. doi: 10.26442/terarkh201890253-58
37. Khalif I.L., Shapina M.V., Orlova L.P., Evgrafov P.G. Ulcerative colitis treatment efficiency assessed by ultrasonography with contrast enhancement. Experimental and clinical gastroenterology. 2018;(5):32-37. (in Russ.)@@ Халиф И.Л., Шапина М.В., Орлова Л.П., Евграфов П.Г. Ультразвуковое исследование с контрастным усилением в оценке эффективности консервативной терапии больных язвенным колитом. Экспериментальная и клиническая гастроэнтерология. 2018;153(5): 32-37.
38. Medellin-Kowalewski A., Wilkens R., Wilson A., Ruan J., Wilson S.R. Quantitative contrast-enhanced ultrasound parameters in Crohn disease: their role in disease activity determination with ultrasound. AJR Am J Roentgenol. 2016;206:64-73. doi: 10.2214/AJR.15.14506.
39. Migaleddu V., Scanu A.M., Quaia E. et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn’s disease. Gastroenterology. 2009;137(1):43-52. doi: 10.1053/j.gastro.2009. 03.062.
40. Ripollés T., Martínez-Pérez M.J., Blanc E. et al. Contrast-enhanced ultrasound (CEUS) in Crohn’s disease: technique, image interpretation and clinical applications. Insights Imaging. 2011;2(6):639-652. doi: 10.1007/s13244-011-0124-1.
41. Wilkens R., Pournazari P., Wilson S.R. CUS of the bowel in inflammatory bowel disease. In: Weskott HP (ed) Contrast-enhanced ultrasound, 2nd edn. Bremen: UNI-MED Verlag AG. 2013:222-236.
42. Serafin Z., Białecki M., Białecka A., Sconfienza L.M., Kłopocka M. Contrast-enhanced Ultrasound for Detection of Crohn’s Disease Activity: Systematic Review and Meta-analysis. J Crohns Colitis. 2016;10(3):354-62. doi: 10.1093/ecco-jcc/jjv196.
Review
For citations:
Mukhametova D.D., Ismailova L.R., Abdulganieva D.I. Contrast-enhanced bowel ultrasound in the diagnosis of inflammatory bowel disease: a literature review. Experimental and Clinical Gastroenterology. 2025;(5):118-126. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-237-5-118-126
Views:
6
Email this article 